// App-Quantinova.ai

LB-392 : Optimizing dual immuno-oncology combinations with a virtual tumor

Researchers

Presenter

  • Fernando Ortega

Principal Investigators

  • Frances A. Brightman

  • Christophe Chassagnole

Medical Centers

  • Physiomics Plc, Oxford, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved